Results of endovascular treatment of multivessel coronary artery disease in patients with the different stent types

Cover Page

Cite item

Full Text

Abstract

Long-term results of endovascular treatment of multivessel coronary artery disease by using different revascularization strategies were analyzed in 171 patients. Duration of follow up ranged from 12 to 18 months. Complete revascularization of the myocardium was performed in 63, culprit vessel revascularization - in 86 and incomplete revascularization - in 22 patients. Patients received different types of stents: bare metal stents and drug eluting stents. The results of this study showed that drug eluting stents has low incidence of repeat PCI procedures and major adverse cardiac events in the long term follow up period regardless the strategy of revascularization had been used.

About the authors

Ye R Khairutdinov

Central clinical hospital № 2 Russian railways

Email: eugkh@yandex.ru <mailto:eugkh@yandex.ru>
Central clinical hospital № 2 Russian railways

Z Kh Shugushev

Central clinical hospital № 2 Russian railways

Central clinical hospital № 2 Russian railways

D A Maximkin

Central clinical hospital № 2 Russian railways

Central clinical hospital № 2 Russian railways

A G Faibushevich

Peoples' Friendship University of Russia

Кафедра госпитальной хирургии с курсом детской хирургииМедицинский факультет; Российский университет дружбы народов; Peoples' Friendship University of Russia

V Yu Baranovich

Peoples' Friendship University of Russia

Кафедра госпитальной хирургии с курсом детской хирургииМедицинский факультет; Российский университет дружбы народов; Peoples' Friendship University of Russia

Yu V Tarichko

Peoples' Friendship University of Russia

Кафедра госпитальной хирургии с курсом детской хирургииМедицинский факультет; Российский университет дружбы народов; Peoples' Friendship University of Russia

References


Copyright (c) 2012 Хайрутдинов Е.Р., Шугушев З.Х., Максимкин Д.А., Файбушевич А.Г., Баранович В.Ю., Таричко Ю.В.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies